ArticleJournal for immunotherapy of cancer2024

GrB-Fc-KS49, an anti-EMP2 granzyme B fusion protein therapeutic alters immune cell infiltration and suppresses breast cancer growth.

Khalid A Mohamedali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.